SEC Provides Relief To Investment Advisers From Form ADV And Form PF Obligations Due To Coronavirus

Update: On March 25, the SEC issued a new order that supersedes the original order discussed below. The new order (1) extends the time period for the relief from April 30 to June 30 and implies that future extensions may be possible, and (2) removes the conditions that an adviser provide a brief description of why it could not meet the deadline and the estimated date by which it expects to file the relevant Form or deliver its Brochure. Our blog post regarding the original order is below.

On March 13, the Securities and Exchange Commission (the "SEC") announced regulatory relief for investment advisers whose operations may be affected by the coronavirus (the "Order"). The relief is limited to filing and delivery obligations originally due prior to April 30. The relief permits those advisers to delay making annual updating amendments to Form ADV (including the Brochure) and Form PF, on the following conditions:

The adviser cannot meet the deadline due to circumstances related to current or potential effects of coronavirus. For Form ADV, the adviser promptly notifies the SEC by email (IARDLive@sec.gov) and discloses to clients and investors either on its website or in a separate communication that it is relying on the Order, a brief description of why it could not meet the deadline, and the estimated date by which it expects to file the Form or deliver its Brochure. For Form PF, the adviser promptly notifies the SEC by email (IARDLive@sec.gov) that it is relying on the Order and a brief description of why it could not timely file the Form. There is no obligation to notify clients and investors. The adviser files the relevant Form (and, if relevant, delivers its Brochure) as soon as practicable, but not...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT